Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.

Abstract excerpt

Linezolid (LNZ) is a promising antimicrobial agent for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB). To investigate the efficacy of LNZ among MDR-TB and XDR-TB in China, the LNZ susceptibility of 158 MDR-TB isolates from the national drug resis...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acetamides
• Share to Antitubercular Agents
• Share to Drug Resistance, Multiple, Bacterial